FDA Approves Generic Vaginal Inserts for Treatment of Menopause Symptoms

Gina Kokosky, Assistant Editor
Published Online: Monday, September 17th, 2018
Generic estradiol vaginal inserts have have received final FDA approval to relieve the symptoms of menopause in women. Glenmark's newly approved Estradiol Vaginal Inserts USP are equivalent to Novo Nordisk’s VAGIFEM.1

Menopause, the time when a woman’s menstrual cycle ends and she is no longer fertile, results in a reduction in both estrogen and progesterone production. Low levels of these 2 hormones can lead to symptoms such as hot flashes, sleep problems, painful sexual intercourse, mood changes, or depression and anxiety.2 Hormone therapy, such as estradiol vaginal inserts, can help replenish estrogen levels and reduce these symptoms, according to the US Department of Health and Human Services’ (HHS) Office on Women’s Health.

The North American Menopause Society notes that vaginally inserted hormone therapy is safe and effective, as the estrogen directly moisturizes and rebuilds vaginal tissue. Vaginal insert hormone therapy has fewer risks than other hormonal therapies, as very little estrogen enters the blood stream.3

While hormone therapy is safe to treat moderate to severe menopause symptoms within 10 years of menopause and up to age 59, researchers note that women should use the lowest dose available for the shortest possible time, according to the HHS’ Office on Women’s Health.2

The newly approved generic vaginal inserts will be available in 10 microgram doses, according to Glenmark.1

  1. Glenmark Pharmaceuticals Receives ANDA Approval for Estradiol Vaginal Inserts USP, 10 mcg [news release]. Mumbai, India; September 17, 2018: Glenmark Pharmaceuticals Inc. Accessed September 17, 2018.
  2. US Department of Health and Human Services’ Office on Women’s HealthMenopause. HHS website. https://www.womenshealth.gov/menopause. Updated May 23, 2018. Accessed September 17, 2018.
  3. Hormone Therapy and Menopause FAQs. The North American Menopause Society website. www.Menopause.org. Accessed September 17, 2018. 

Current Issue

The Educated Patient

Bethany Rettberg, NPC
Practitioners should get a detailed medical history and conduct a thorough physical to treat sinus infections.
Jennifer L. Hofmann, MS, PA-C
Providing them with advice can improve control of the disease and reduce hospitalizations, morbidity, and unscheduled health care visits.
Emily C. Hayes, PharmD Candidate
Colds, coughs, and a relentless influx of sick patients in retail health clinics keep the health care providers who work there very busy.
Kristen Marjama, DNP, APRN-BC
Although the rate of foot and leg amputation has greatly declined over the past 2 decades, increasing awareness for macrovascular and microvascular complications of diabetes is essential because diabetes is the leading cause of lower-limb amputations in the United States.
$vacMongoViewPlus$ $vAR$
Contemporary Clinic
MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Specialty Pharmacy Times
Targeted Oncology
About Us
Contact Us
Terms & Conditions
Pharmacy Healthcare & Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-257-0701

Copyright Contemporary Clinic 2018
Pharmacy Healthcare & Communications, LLC. All Rights Reserved.